• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏蛋白保护型植物源疗法对给予健康犬21天的卡洛芬和罗贝考昔所致结肠黏膜损伤的影响。

Effect of mucoprotective plant-derived therapies on damage to colonic mucosa caused by carprofen and robenacoxib administered to healthy dogs for 21 days.

作者信息

Szweda Magdalena, Szarek Józef, Dublan Krystyna, Męcik-Kronenberg Tomasz, Kiełbowicz Zdzisław, Bigoszewski Marcin

机构信息

a Forensic Veterinary Medicine and Administration , University of Warmia and Mazury , Olsztyn , Poland.

出版信息

Vet Q. 2014;34(4):185-93. doi: 10.1080/01652176.2014.968939. Epub 2014 Oct 20.

DOI:10.1080/01652176.2014.968939
PMID:25330194
Abstract

BACKGROUND

Non-steroidal anti-inflammatory drugs (NSAIDs) may cause gastrointestinal damage in dogs.

HYPOTHESIS/OBJECTIVES: To determine the extent to which lansoprazole, liquorice extract, and a herbal solution exhibit protective effects on colonic mucosa when administered to dogs concurrently with the NSAIDs carprofen or robenacoxib.

ANIMALS AND METHODS

Thirty-five healthy beagle dogs (15 male and 20 female) aged 13-14 weeks and weighing 4.3-5.5 kg at the beginning of the experiment were included. Endoscopy and biopsy of the caudal gastrointestinal tract were performed pretreatment and on the last day of a 21-day treatment period with (1) oral carprofen; (2) carprofen and the proton-pump inhibitor lansoprazole; (3) carprofen, liquorice extract, and a herbal solution that contained extracts of thyme, icelandic lichen, hyssop, and saponariae root; (4) robenacoxib; (5) robenacoxib and lansoprazole; (6) robenacoxib, liquorice extract, and herbal solution; or (7) an empty gelatin capsule. Statistical analyses were performed with the Kruskal-Wallis, Cochran's Q, and chi-squared test with p < 0.05 considered significant.

RESULTS

Both carprofen and robenacoxib tested damaged the colonic mucosa with most severe microscopic lesions following administration of robenacoxib with lansoprazole. The risk of histopathological lesions in the colon increased most rapidly in robenacoxib with lansoprazole (absolute risk increase -0.85) similar to robenacoxib only (-0.75), whereas the best result was recorded following the plant remedies together with carprofen (-0.15) and the plant remedies together with robenacoxib (-0.2).

CONCLUSIONS AND CLINICAL IMPORTANCE

Concurrent administration of liquorice extract and an herbal solution with robenacoxib was associated with decreased severity of the NSAID-induced mucosal lesions.

摘要

背景

非甾体抗炎药(NSAIDs)可能会对犬类造成胃肠道损伤。

假设/目的:确定兰索拉唑、甘草提取物和一种草药溶液在与NSAIDs卡洛芬或罗贝考昔同时给犬使用时,对结肠黏膜的保护作用程度。

动物与方法

纳入35只健康的比格犬(15只雄性和20只雌性),实验开始时年龄为13 - 14周,体重4.3 - 5.5千克。在21天的治疗期前以及最后一天,对尾段胃肠道进行内镜检查和活检,治疗分组如下:(1)口服卡洛芬;(2)卡洛芬与质子泵抑制剂兰索拉唑;(3)卡洛芬、甘草提取物以及一种含有百里香、冰岛地衣、牛膝草和皂草根提取物的草药溶液;(4)罗贝考昔;(5)罗贝考昔与兰索拉唑;(6)罗贝考昔、甘草提取物和草药溶液;或(7)空明胶胶囊。采用Kruskal - Wallis检验、Cochran's Q检验和卡方检验进行统计分析,p < 0.05认为具有显著性。

结果

卡洛芬和罗贝考昔均检测出会损伤结肠黏膜,在罗贝考昔与兰索拉唑联合给药后出现最严重的微观病变。罗贝考昔与兰索拉唑联合使用时结肠组织病理学损伤风险增加最快(绝对风险增加 -0.85),与仅使用罗贝考昔时(-0.75)相似,而植物疗法与卡洛芬联合使用(-0.15)以及植物疗法与罗贝考昔联合使用(-0.2)时效果最佳。

结论及临床意义

甘草提取物和草药溶液与罗贝考昔联合使用可降低NSAIDs诱导的黏膜损伤严重程度。

相似文献

1
Effect of mucoprotective plant-derived therapies on damage to colonic mucosa caused by carprofen and robenacoxib administered to healthy dogs for 21 days.黏蛋白保护型植物源疗法对给予健康犬21天的卡洛芬和罗贝考昔所致结肠黏膜损伤的影响。
Vet Q. 2014;34(4):185-93. doi: 10.1080/01652176.2014.968939. Epub 2014 Oct 20.
2
Can liquorice extract and herbal solution prevent colonic mucosa damage caused by robenacoxib in dogs?甘草提取物和草药溶液能预防罗贝考昔对犬结肠黏膜造成的损伤吗?
Pol J Vet Sci. 2015;18(4):793-8. doi: 10.1515/pjvs-2015-0103.
3
Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial.罗贝考昔与卡洛芬治疗犬骨关节炎的随机非劣效性临床试验
J Vet Pharmacol Ther. 2012 Apr;35(2):175-83. doi: 10.1111/j.1365-2885.2011.01297.x. Epub 2011 Apr 12.
4
Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2.罗贝考昔在犬类中的应用:与COX-1和COX-2抑制程度及持续时间相关的目标物种安全性
J Vet Pharmacol Ther. 2011 Jun;34(3):298-311. doi: 10.1111/j.1365-2885.2010.01209.x.
5
Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs.罗贝考昔(欧适宝™)片剂与注射用溶液在犬类中交替使用的安全性评估。
BMC Vet Res. 2017 Nov 28;13(1):359. doi: 10.1186/s12917-017-1269-z.
6
Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial.口服罗贝考昔与卡洛芬治疗犬骨关节炎的比较:一项随机临床试验。
J Vet Med Sci. 2012 Sep;74(9):1121-31. doi: 10.1292/jvms.11-0529. Epub 2012 May 17.
7
Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations.罗贝考昔片(昂适™)每日口服给药后对犬的六个月安全性评估。
BMC Vet Res. 2018 Aug 17;14(1):242. doi: 10.1186/s12917-018-1566-1.
8
Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs.口服罗贝考昔(片剂)治疗宠物犬软组织手术相关疼痛的疗效和安全性。
BMC Vet Res. 2017 Jun 26;13(1):197. doi: 10.1186/s12917-017-1100-x.
9
Effects of carprofen on the integrity and barrier function of canine colonic mucosa.卡洛芬对犬结肠黏膜完整性和屏障功能的影响。
Am J Vet Res. 2008 Feb;69(2):174-81. doi: 10.2460/ajvr.69.2.174.
10
In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.罗非昔布对犬环氧化酶同工酶的体外和离体抑制作用:比较研究。
Res Vet Sci. 2010 Jun;88(3):497-506. doi: 10.1016/j.rvsc.2009.11.002. Epub 2009 Dec 11.

引用本文的文献

1
Phytotherapeutic Approaches in Canine Pediatrics.犬科儿科学中的植物疗法
Vet Sci. 2024 Mar 20;11(3):133. doi: 10.3390/vetsci11030133.
2
Can L. reduce both upper gastrointestinal tract bleeding and ventilator-associated pneumonia in intensive-care unit patients?L能否降低重症监护病房患者的上消化道出血和呼吸机相关性肺炎的发生率?
Focus Altern Complement Ther. 2015 Dec;20(3-4):184-186. doi: 10.1111/fct.12198. Epub 2015 Jul 23.